Back to D1 Capital Partners L.P.

LXEO
Showing 7 of 8 quarters

Position history for D1 Capital Partners L.P.'s holdings in LEXEO THERAPEUTICS INC

D1 Capital Partners L.P. previously held 0 shares of LXEO (LEXEO THERAPEUTICS INC), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$40.2M

Total Shares Change

-2.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$9.74
0
2025-Q3
Unchanged
978,652
0.0%
$6.5M0.1%$6.66
0
2025-Q2
Unchanged
978,652
0.0%
$3.9M0.1%$4.12
0
2025-Q1
Decreased
978,652
-55.6%
$3.4M0.1%$4.10
0
2024-Q4
Decreased
2.2M
-12.1%
$14.5M0.2%$6.54
0
2024-Q3
Unchanged
2.5M
0.0%
$22.7M0.4%$9.11
0
2024-Q2
Unchanged
2.5M
0.0%
$40.2M0.7%$16.04
0

Other major holders of LXEO: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used